BBZA.DE लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 21:05):

Stats
आज की मात्रा	19 392.00
औसत मात्रा	24 517.00
बाजार मूल्य	2.39B
EPS	€0 ( 2023-10-20 )
अगली कमाई की तारीख	( €0 ) 2024-07-26
Last Dividend	€2.85 ( 2023-03-27 )
Next Dividend	€0 ( N/A )
P/E	-11.27
ATR14	€0.0890 (0.21%)

मात्रा सहसंबंध

लंबा: -0.04 (neutral)

छोटा: -0.43 (neutral)

Signal:(46.327) Neutral

BB Biotech AG सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

BB Biotech AG सहसंबंध - मुद्रा/वस्त्र

0.53
( weak )

0.68
( moderate )

0.00
( neutral )

-0.62
( weak negative )

BB Biotech AG वित्तीय

Annual	2023
राजस्व:	€-199.57M
सकल लाभ:	€-199.57M (100.00 %)
EPS:	€-3.77

FY	2023
राजस्व:	€-199.57M
सकल लाभ:	€-199.57M (100.00 %)
EPS:	€-3.77

FY	2022
राजस्व:	€-351.23M
सकल लाभ:	€-351.23M (100.00 %)
EPS:	€-6.50

FY	2021
राजस्व:	€-396.22M
सकल लाभ:	€0.00 (0.00 %)
EPS:	€-7.31

Financial Reports:

No articles found.

BB Biotech AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€2.85 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

BB Biotech AG Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.05 - Stable (20.98%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€3.60	2021-03-22
Last Dividend	€2.85	2023-03-27
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	€10.30	--
Avg. Dividend % Per Year	0.00%	--
Score	3.31	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.05
Div. Directional Score	9.28	--

Next Divdend (Est)
(2024-12-31)

€0 Estimate 0.00 %

Dividend Stability

0.07 Very Bad

Dividend Score

3.31

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
NTG.DE	Ex Dividend Junior	2023-06-29	Sporadic	0.00%
7F8.F	Ex Dividend Knight	2023-09-06	Semi-Annually	0.00%
G24.DE	Ex Dividend Junior	2023-06-23	Annually	0.00%
PWO.DE	Ex Dividend Junior	2023-05-11	Sporadic	0.00%
ASME.DE	Ex Dividend Knight	2023-08-01	Semi-Annually	0.00%
IBE1.DE	Ex Dividend Knight	2023-07-07	Semi-Annually	0.00%
SY1.DE	Ex Dividend Knight	2023-05-11	Annually	0.00%
CGN.DE	Ex Dividend Knight	2023-09-05	Quarterly	0.00%
LIN.DE	Ex Dividend Knight	2023-09-01	Quarterly	0.00%
VNA.F	Ex Dividend Junior	2023-05-18	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.915	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.109	1.200	6.37	7.65	[0 - 0.3]
returnOnEquityTTM	0.133	1.500	9.64	10.00	[0.1 - 1]
payoutRatioTTM	0.356	-1.000	6.44	-6.44	[0 - 1]
currentRatioTTM	7.99	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.97	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.00114	1.500	-1.105	-1.657	[0.2 - 2]
debtRatioTTM	0.122	-1.500	7.97	-10.00	[0 - 0.6]
interestCoverageTTM	65.89	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	1.576	2.00	9.47	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.576	2.00	9.21	10.00	[0 - 20]
debtEquityRatioTTM	0.139	-1.500	9.44	-10.00	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.919	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.251	1.000	9.72	9.72	[0.2 - 2]
assetTurnoverTTM	0.119	0.800	-2.54	-2.03	[0.5 - 2]
Total Score				12.51

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.54	1.000	9.34	0	[1 - 100]
returnOnEquityTTM	0.133	2.50	9.77	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.576	2.00	9.47	10.00	[0 - 30]
dividendYielPercentageTTM	4.87	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.576	2.00	9.47	10.00	[0 - 30]
payoutRatioTTM	0.356	1.500	6.44	-6.44	[0 - 1]
pegRatioTTM	0.0417	1.500	-3.06	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.257	1.000	6.08	0	[0.1 - 0.5]
Total Score				6.05

BB Biotech AG

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.